E642-0313 Screening compound: N-benzyl-4-[({3-[(2-fluorophenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]benzamide

E642-0313 Screening compound: N-benzyl-4-[({3-[(2-fluorophenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]benzamide
E642-0313 Screening compound: N-benzyl-4-[({3-[(2-fluorophenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E642-0313
N-benzyl-4-[({3-[(2-fluorophenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E642-0313

Molecular Formula

C28H23FN4OS (C28 H23 FN4 OS)

Compound Name

N-benzyl-4-[({3-[(2-fluorophenyl)methyl]-3H-imidazo[4,5-b]pyridin-2-yl}sulfanyl)methyl]benzamide

IUPAC name

N-benzyl-4-[({3-[(2-fluorophenyl)methyl]-3H-imidazo[45-b]pyridin-2-yl}sulfanyl)methyl]benzamide

SMILES

O=C(c1ccc(CSc(n2Cc(cccc3)c3F)nc3c2nccc3)cc1)NCc1ccccc1

InChI

InChI=1S/C28H23FN4OS/c29-24-10-5-4-9-23(24)18-33-26-25(11-6-16-30-26)32-28(33)35-19-21-12-14-22(15-13-21)27(34)31-17-20-7-2-1-3-8-20/h1-16H,17-19H2,(H,31,34)

InChI Key

NUEHWIRPIFTSKU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14906643

Chemical and Physical Properties

Saltdata

HOOCCOOH

Molecular Weight

482.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.303

Distribution Coefficient, logD

5.303

Water Solubility, LogSw

-5.65

Polar Surface Area

44.797

Acid Dissociation Constant (pKa)

11.60

Base Dissociation Constant (pKb)

4.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.70

E642-0313 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with E642-0313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E642-0313?
Check Price and Availability of E642-0313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E642-0313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E642-0313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E642-0313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E642-0313 available by request